Photo by National Cancer Institute on Unsplash
Panna Sharma, CEO and President of Lantern Pharma Inc. LTRN, was a guest speaker at Benzinga’s All Access on Jan. 28, 2022.
Panna discussed how Lantern Pharma is attempting to transform oncology drug development through data. Via AI and machine learning, the company has developed the means to harness data to optimize drug development processes - rescuing old drugs, relaunching them in the right settings, and developing new drugs and treatments.
Watch the full interview here:
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.